Pulse Biosciences, Inc (PLSE)'s Technical Outlook is Bright After Key Golden Cross

In this article:

Pulse Biosciences, Inc (PLSE) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, PLSE's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross."

There's a reason traders love a golden cross -- it's a technical chart pattern that can indicate a bullish breakout is on the horizon. This kind of crossover is formed when a stock's short-term moving average breaks above a longer-term moving average. Typically, a golden cross involves the 50-day and the 200-day moving averages, since bigger time periods tend to form stronger breakouts.

A successful golden cross event has three stages. It first begins when a stock's price on the decline bottoms out. Then, its shorter moving average crosses above its longer moving average, triggering a positive trend reversal. The third and final phase occurs when the stock maintains its upward momentum.

This kind of chart pattern is the opposite of a death cross, which is a technical event that suggests future bearish price movement.

PLSE has rallied 5.7% over the past four weeks, and the company is a #3 (Hold) on the Zacks Rank at the moment. This combination indicates PLSE could be poised for a breakout.

Once investors consider PLSE's positive earnings outlook for the current quarter, the bullish case only solidifies. No earnings estimate has gone lower in the past two months compared to 1 revisions higher, and the Zacks Consensus Estimate has increased as well.

Moving Average Chart for PLSE
Moving Average Chart for PLSE

Given this move in earnings estimates and the positive technical factor, investors may want to keep their eye on PLSE for more gains in the near future.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Pulse Biosciences, Inc (PLSE) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Advertisement